MORE►
Samarendra Mohanty
Bedford-based Nanoscope Instruments Inc.’s new patent covers an apparatus and method for measuring the functional vision of patients with low vision. [Illustration: Sources, USPTO Patent No. 12702291-B2; DI Studio]
Patented: Nanoscope Instruments’ Low-Vision Function Test and 134 More Inventions Across North Texas
by Dave Head | Sep 2, 2026
Dallas-Fort Worth ranked No. 9 among 250 U.S. metros in patent production for the week of Aug. 11, with 135 patents granted to inventors and companies across the region.
by Kevin Cummings |
Oct 18, 2022
Dallas-based Nanoscope Therapeutics is accelerating the development of therapies that could restore sight in patients with the help of a publicly traded firm. The retinal degenerative diseases-focused biotech company announced a new gene therapy manufacturing partnership with contract research organization Charles River Laboratories International.
MORE►
by David Seeley |
Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE►
